Cisplatin is one of the most effective cancer drugs we have — but it comes with a tough tradeoff: permanent hearing loss in up to half of patients who receive it.
NIH scientists led by Dr. Lisa Cunningham are testing whether a common cholesterol drug, atorvastatin, can reduce
NIH’s National Institute on Deafness and Other Communication Disorders (NIDCD) wants to hear from you!
NIDCD seeks comments and suggestions from the public in response to this question:
Are there new and emerging areas of science with the potential to impact the health and
What does it take to turn a discovery into a breakthrough? Decades of diligent work.
NIH vision scientist Dr. Michael Redmond’s life’s work led to the discovery of a gene associated with a retinal dystrophy that causes blindness.
Read how this discovery paved the way for an
Interested in building biomedical research capacity at your institution?
Join NIH for an informational webinar on September 9 from 3:00-4:30 p.m. ET. Learn about the COBRE-D funding opportunity, program goals, application considerations, and get answers to your questions.
🔗
